(Q64222960)

English

A Randomized, Double-blind Clinical Trial to Evaluate the Safety and Efficacy of the X5 HairLaser for the Treatment of Androgenetic Alopecia in Males

clinical trial

In more languages

edit

Statements

instance of

clinical trial

0 references

title

A Randomized, Double-blind Clinical Trial to Evaluate the Safety and Efficacy of the X5 HairLaser for the Treatment of Androgenetic Alopecia in Males (English)

0 references

0 references

0 references

United States of America

0 references

end time

April 2010

0 references

research site

Burke Pharmaceutical Research

0 references

New York University

0 references

minimum age

20 year

0 references

maximum age

60 year

0 references

study type

interventional study

0 references

Identifiers

ClinicalTrials.gov ID

NCT02067260

0 references

(Q64222960)

A Randomized, Double-blind Clinical Trial to Evaluate the Safety and Efficacy of the X5 HairLaser for the Treatment of Androgenetic Alopecia in Males

Statements

Identifiers

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)